Important Therapy Provides Six Months Pain Relief with Single Injection CAMBRIDGE, Mass.–(HSMN NewsFeed)–Genzyme Corporation (Nasdaq: GENZ ) today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Synvisc-On…
Biopharmaceuticals, FDA
Genzyme, Synvisc-One, hylan G-F Twenty, osteoarthritis
Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.
To get the details: Click Here
0 Comments on “FDA Approves Genzyme’s Synvisc-One for Osteoarthritis of the Knee”
Leave a Comment